The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients

NCT05279937 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ehlers-Danlos Syndrome
Low Back Pain
Sacroiliac Instability

Interventions

DRUG: Dextrose 50% Intravenous Solution
DRUG: Lidocaine 1% Injectable Solution

Sponsor

Tulane University